February, 2024
February 2024
OncoDaily Dialogues #4 – Therese Mulvey / Hosted by Roupen Odabashian
Dec 26, 2023, 04:08

OncoDaily Dialogues #4 – Therese Mulvey / Hosted by Roupen Odabashian

In our series “OncoDaily Dialogues,” we continue to spotlight eminent figures in oncology, sharing their successes, challenges, and pivotal experiences.

Today, we are honored to welcome a prominent oncologist from the Massachusetts General Hospital, Dr. Therese Mulvey.

Dr Mulvey is the director of Breast Oncology at the Massachusetts General Hospital (MGH) North Shore Cancer Center, a community affiliate in Danvers, Massachusetts. She also serves as the director of Quality Safety and Value for the MGH Cancer Center and Network Affiliates. She was previously the physician-in-chief at Southcoast Centers for Cancer Care in New Bedford, Massachusetts. Dr. Mulvey has previously worked as a physician at other community practices in Massachusetts, including East Boston Neighborhood Health Center and Commonwealth Hematology Oncology, where she also served as president and CEO.

Dr. Mulvey is a Fellow of the American Society of Clinical Oncology (FASCO). She served as chair of the ASCO Clinical Practice Committee and on the Editorial Board of the Journal of Oncology Practice. She has served on the Cancer Quality Alliance and as chair of the Oncology Carrier Advisory Committee. Dr. Mulvey recently served on the Board of Directors of ASCO.

She was the President of the Massachusetts Society of Clinical Oncology.

Dr. Mulvey is a recipient of the ASCO Statesman Award, Goodspeed Chair Award and Lecture for Quality Care, Elizabeth Seton Humanitarian Award.

Dr. Mulvey received her medical degree from Tufts University School of Medicine, and completed her internship, residency, and fellowship at Tufts New England Medical Center. She completed a research and clinical fellowship at Massachusetts General Hospital.

Our host is Dr. Roupen Odabashian, hematology/oncology fellow at Karmanos Cancer Institute in Detroit, USA. Beyond his clinical practice, Dr. Odabashian possesses an unwavering passion for delving into the intricacies of healthcare policy, regulations and Oncology. He understands the multifaceted nature of cancer as a medical condition and acknowledges the various stakeholders and regulatory bodies that influence the delivery and administration of cancer treatments. In alignment with this commitment, he has joined OncoDaily, where he plays a pivotal role in conducting interviews with Leaders of the Cancer world.


About OncoDaily

OncoDaily is a leading oncology media platform based in the United States, which features the latest news, insights, and patient stories from the world of oncology.  The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”.


Previous series:

OncoDaily Dialogues #1 – Harout Semerjian / Hosted by Roupen Odabashian

OncoDaily Dialogues #2 – Piotr Wysocki / Hosted by Roupen Odabashian

OncoDaily Dialogues #3 – Andrés Wiernik / Hosted by Roupen Odabashian